Therapeutic inhibition of DNA-Damage Response and PI3K/AKT signaling in Acute Myleoid Leukemia: A novel therapeutic strategy to boost chemotherapy response and overcome resistance
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | J Cell Immunol |
Status | Afsendt - 2024 |
ID: 290193502